Centrillion Technologies

Centrillion Technologies

Genomics DNA analysis and sequencing tools

Overview

Centrillion Technologies develops tools for genomic studies, including sequencing, bioinformatics, and a new generation of DNA chips designed for high-density, high-quality probes that work with sequencing. Its products include ATOM, a high-throughput detection system, and VirusHunter MVP, a pathogen-detection assay, along with sequencing and droplet digital PCR services for researchers and drug discovery groups. It differentiates itself by offering integrated genomics hardware, assays, and services with DNA chips optimized for large-scale analysis that complement sequencing workflows. Its goal is to enable broad, scalable genomic studies to accelerate drug discovery, personalized medicine, and molecular diagnostics.

About Centrillion Technologies

Simplify's Rating
Why Centrillion Technologies is rated
C-
Rated C on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Data & Analytics

Enterprise Software

Biotechnology

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$24.3M

Headquarters

Palo Alto, California

Founded

2009

Get referred to Centrillion Technologies

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The company updated its site on 2026-08-13, showing active product maintenance.
  • Homepage claims rapid multiplex pathogen detection, whole genome viral sequencing, and human genotyping.
  • Earlier WeDoctor and Arm IoT investments provided capital and China manufacturing expansion capacity.

What critics are saying

  • Centrillion's 2026 site still markets SARS-CoV-2 products, signaling pandemic-demand dependence.
  • VirusHunter MVP is only available through Molecular Vision laboratories, limiting direct customer control.
  • No recent funding, revenue, or regulatory filings surfaced; sustained commercialization remains unproven.

What makes Centrillion Technologies unique

  • In-situ synthesized DNA chips enable billions of sensors on one wafer, per 2026 website.
  • QuadCore and ATOM chips combine pathogen detection, viral sequencing, genotyping, and spatial transcriptomics.
  • VirusHunter assays bundle chip hardware with molecular lab workflows, not standalone reagents.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$24.3M

Below

Industry Average

Funded Over

4 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Below Average

Industry standards

$35M
$30M
Patreon
$45M
Linktree
$65M
Substack
$100M
ClickUp

Growth & Insights

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

4%

Recently Posted Jobs

Sign up to get curated job recommendations

Centrillion Technologies is Hiring for 28 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →